Novartis Investigative Site

Catanzaro 88100

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myeloid Leukemia, Partial Onset Seizures

Studies at this site

• Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures — Completed
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE